Navigation Links
PTC Therapeutics Expands Management Team
Date:10/1/2013

s in other industries including: New York Life Insurance Company and Altria Corporate Services, Inc. Mr. Rexroad received an M.S. in Business Administration focusing on Human Resources and Labor Relations and a B.S. in Business Management from Virginia Tech.

"I am delighted to join PTC at this exciting time in the company's history," stated Mr. Martin Rexroad, Senior Vice President, Human Resources, PTC Therapeutics, Inc. "PTC is at a critical stage of its development, as a newly public company with lead product candidates in late-stage clinical trials. I look forward to being part of PTC's growth and development. The culture of innovation, collaboration and high scientific standards at PTC is parallel only to its commitments to patients and creates a remarkable work environment."

Mr. R.A. Session II returns to PTC to work cross-functionally in corporate strategy, commercial development and finance. Prior to joining PTC, Mr. Session was Senior Director, Strategic Planning & Finance at Reata Pharmaceuticals where he led strategic analytics, valuation analysis, market access, pricing and long-range planning. Mr. Session was an integral part of the deal teams that successfully completed two of the largest licensing transactions in pharmaceutical history. Prior to Reata, Mr. Session served as Associate Director Strategic Planning & Finance at PTC from 2008 to 2010. Mr. Session has held various positions in strategic planning, drug development, and commercialization at other leading pharmaceutical companies including: AstraZeneca and Johnson & Johnson. He holds an MBA and MSF from Texas A&M University at Commerce, College of Business and Technology and a B.S. from the University of North Carolina at Charlotte, Belk College of Business.

Dr. Jay Barth leads PTC's clinical team and oversees all clinical trials at the company. Dr. Barth joined PTC in 20
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CIO Review ( http://www.cioreview.com ) has ... Promising Pharma and Life Science Technology Solution Providers 2015. ... software platform for life sciences companies. , The ... of experts and members of CIO Review’s editorial board ... has been on our radar for some time now ...
(Date:4/17/2015)... -- Guggenheim Securities, the investment banking and capital markets division ... William Tanner as a Managing Director and senior ... work at Guggenheim in May 2015 in the firm,s ... "Bill brings a wealth of biotech experience, in both ... acclaimed healthcare team," said Matthew Johnson , Senior ...
(Date:4/17/2015)... 17, 2015 Global Stem Cells ... Stem Cell Summit 2015 April 27 - 29, 2015 ... developments in all areas of stem cell research including ... cells and regenerative medicine. , The conference will ... well as translational research in stem cell therapies, regenerative ...
(Date:4/17/2015)... April 17, 2015 BellBrook Labs ... marketing support for the powerful Orthogonal Pooled Screening ... Genomics Center at the Lankenau Institute for Medical ... is to measurably improve successful drug discovery outcomes ... offering rare, drug-like libraries available nowhere else, coupled ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 3BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2
... vital to the success of his or her business, and ... definitive answer. Finding and keeping the right employees, affording health ... are common replies. , ,Holding down taxes? That's on the ... order depends on the entrepreneur. Those who aren't yet turning ...
... one of our exclusive interview with new TDS Telecom ... in transforming TDS from a phone company to a broadband provider. ... to drive innovation, and explains why every TDS employee has a ... part one ) , , WTN: How would you describe ...
... address the lack of an effective delivery method in ... has entered into a two-year, multimillion dollar agreement with ... models. , ,Russell Smestad, president of Mirus Bio, said ... Achilles' heel that has impeded progress in RNA interference, ...
Cached Biology Technology:High taxes and low rates of entrepreneurship - is there a relationship? 2High taxes and low rates of entrepreneurship - is there a relationship? 3New CEO at TDS on creating a culture of innovation (Part 2) 2New CEO at TDS on creating a culture of innovation (Part 2) 3New CEO at TDS on creating a culture of innovation (Part 2) 4Mirus Bio, Pfizer enter multimillion-dollar research agreement 2
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2
... could help make DNA sequencing affordable enough for clinics ... Andrew Smith, a computational biologist at the USC Dornsife College ... USC graduate student Timothy Daley to help predict the value ... Methods on February 24. Extracting information from ...
... The Children,s Medical Center Research Institute at ... environment within bone marrow that nurtures stem cells, this ... that produce the infection-fighting white blood cells known as ... that cells called early lymphoid progenitors, which are responsible ...
... Bahrami will use his expertise in cooling and heating ... to develop green air conditioning and refrigeration systems (AC-R) ... service vehicle and long-haul truck idling engines. With ... Partnership Canada, the associate professor in Mechatronic Systems Engineering ...
Cached Biology News:Taking the gamble out of DNA sequencing 2Scientists find bone-marrow environment that helps produce infection-fighting T and B cells 2Clean energy research targets idle engines 2Clean energy research targets idle engines 3
... with a modular approach to instrument control, ... Plus NDS family provides modular software components ... management, giving you the flexibility to choose ... now and that can grow as your ...
... solution is a highly scalable analysis ... data in a workgroup or an ... over 40 leading pharmaceutical, biotechnology, academic ... Workgroup streamlines genomics research at large ...
... scale kinase profiling, quantitative measurement of ... research built on the flexible and ... These microarrays are available as part ... - Peptide Microarray Service. ...
... 18 amino acid synthetic peptide whose sequences are derived from mouse ... carboxy terminus): S(21) - S - M - P - L ... A - I - D - K - K - I ... peptide may be used for neutralization and control experiments with the ...
Biology Products: